CoChat

Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy

Roth, Fanny, Dhiab, Jamila, Boulinguiez, Alexis, Mouigni, Hadidja-Rose, Lassche, Saskia, Negroni, Elisa, Muraine, Laura, Marhic, Alix, Oliver, Alison, Lainé, Jeanne, Rouche, Andrée, O’Ferrall, Erin K., van Engelen, Baziel, Ottenheijm, Coen, Greif, Hagar, Blumen, Sergiu, Lacau St Guily, Jean, Perie, Sophie, Butler-Browne, Gillian, Mouly, Vincent, Trollet, Capucine · 2022 · Acta Neuropathologica
Cited by 18

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is a rare muscle disease characterized by an onset of weakness in the pharyngeal and eyelid muscles. The disease is caused by the extension of a polyalanine tract in the Poly(A) Binding Protein Nuclear 1 (PABPN1) protein leading to the formation of intranuclear inclusions or aggregates in the muscle of OPMD patients. Despite numerous studies stressing the deleterious role of nuclear inclusions in cellular and animal OPMD models, their exact contribution to human disease is still unclear. In this study, we used a large and unique collection of human muscle biopsy samples to perform an in-depth analysis of PABPN1 aggregates in relation to age, genotype and muscle status with the final aim to improve our understanding of OPMD physiopathology. Here we demonstrate that age and genotype influence PABPN1 aggregates: the percentage of myonuclei containing PABPN1 aggregates increases with age and the chaperone HSP70 co-localize more frequently with PABPN1 aggregates with a larger polyalanine tract. In addition to the previously described PRMT1 and HSP70 co-factors, we identified new components of PABPN1 aggregates including GRP78/BiP, RPL24 and p62. We also observed that myonuclei containing aggregates are larger than myonuclei without. When comparing two muscles from the same patient, a similar amount of aggregates is observed in different muscles, except for the pharyngeal muscle where fewer aggregates are observed. This could be due to the peculiar nature of this muscle which has a low level of PAPBN1 and contains regenerating fibers. To confirm the fate of PABPN1 aggregates in a regenerating muscle, we generated a xenograft model by transplanting human OPMD muscle biopsy samples into the hindlimb of an immunodeficient mouse. Xenografts from subjects with OPMD displayed regeneration of human myofibers and PABPN1 aggregates were rapidly present—although to a lower extent-after muscle fiber regeneration. Our data obtained on human OPMD samples add support to the dual non-exclusive models in OPMD combining toxic PABPN1 intranuclear inclusions together with PABPN1 loss of function which altogether result in this late-onset and muscle selective disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-022-02503-7

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 71

  1. Abu-Baker A, Laganiere S, Fan X, Laganiere J, Brais B, Rouleau GA (2005) Cytoplasmic targeting of mutant Poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy. Traffic 6:766–779. https://doi.org/10.1111/j.1600-0854.2005.00315.x · DOI
  2. Abu-Baker A, Messaed C, Laganiere J, Gaspar C, Brais B, Rouleau GA (2003) Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy. Hum Mol Genet 12:2609–2623. https://doi.org/10.1093/hmg/ddg293 · DOI
  3. Agarwal PK, Mansfield DC, Mechan D, Al-Shahi Salman R, Davenport RJ, Connor M et al (2012) Delayed diagnosis of oculopharyngeal muscular dystrophy in Scotland. Br J Ophthalmol 96:281–283. https://doi.org/10.1136/bjo.2010.200378 · doi:10.1136/bjo.2010.200378
  4. Anvar SY, AC’t Hoen P, Venema A, Van Der Sluijs B, Van Engelen B, Snoeck M et al (2011) Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients. Skeletal muscle 1:1 · DOI
  5. Apponi LH, Corbett AH, Pavlath GK (2013) Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle. Skelet Muscle 3:23. https://doi.org/10.1186/2044-5040-3-23 · DOI · Paper page
  6. Argov Z, Gliko-Kabir I, Brais B, Caraco Y, Megiddo D (2016) Intravenous trehalose improves dysphagia and muscle function in oculopharyngeal muscular dystrophy (OPMD): preliminary results of 24 weeks open label phase 2 trial (I4.007). Neurology 86:I4.007 · doi:10.1212/wnl.86.16_supplement.i4.007
  7. Ayyadevara S, Balasubramaniam M, Suri P, Mackintosh SG, Tackett AJ, Sullivan DH et al (2016) Proteins that accumulate with age in human skeletal-muscle aggregates contribute to declines in muscle mass and function in Caenorhabditis elegans. Aging (Albany NY) 8:3486–3496. https://doi.org/10.18632/aging.101141 · DOI · Paper page
  8. Banerjee A, Apponi LH, Pavlath GK, Corbett AH (2013) PABPN1: molecular function and muscle disease. FEBS J 280:4230–4250. https://doi.org/10.1111/febs.12294 · DOI · Paper page
  9. Bao YP, Sarkar S, Uyama E, Rubinsztein DC (2004) Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy. J Med Genet 41:47–51. https://doi.org/10.1136/jmg.2003.014548 · DOI
  10. Becher MW, Kotzuk JA, Davis LE, Bear DG (2000) Intranuclear inclusions in oculopharyngeal muscular dystrophy contain poly(A) binding protein 2. Ann Neurol 48:812–815 · doi:10.1002/1531-8249(200011)48:5<812::aid-ana20>3.0.co;2-2
  11. Beltran Valls MR, Wilkinson DJ, Narici MV, Smith K, Phillips BE, Caporossi D et al (2015) Protein carbonylation and heat shock proteins in human skeletal muscle: relationships to age and Sarcopenia. J Gerontol: Series A 70:174–181. https://doi.org/10.1093/gerona/glu007 · DOI · Paper page
  12. Bengoechea R, Tapia O, Casafont I, Berciano J, Lafarga M, Berciano MT (2012) Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy. Neurobiol Dis 46:118–129. https://doi.org/10.1016/j.nbd.2011.12.052 · doi:10.1016/j.nbd.2011.12.052
  13. Bensalah M, Muraine L, Boulinguiez A, Giordani L, Albert V, Ythier V et al (2022) A negative feedback loop between fibroadipogenic progenitors and muscle fibres involving endothelin promotes human muscle fibrosis. J Cachexia, Sarcopenia Muscle n/a. https://doi.org/10.1002/jcsm.12974 · DOI
  14. Blanc RS, Richard S (2017) Regenerating muscle with arginine methylation. Transcription 8:175–178. https://doi.org/10.1080/21541264.2017.1291083 · DOI
  15. Blumen SC, Brais B, Korczyn AD, Medinsky S, Chapman J, Asherov A et al (1999) Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease. Ann Neurol 46:115–118 · doi:10.1002/1531-8249(199907)46:1<115::aid-ana17>3.0.co;2-o
  16. Blumen SC, Sadeh M, Korczyn AD, Rouche A, Nisipeanu P, Asherov A et al (1996) Intranuclear inclusions in oculopharyngeal muscular dystrophy among Bukhara Jews. Neurology 46:1324–1324. https://doi.org/10.1212/WNL.46.5.1324 · DOI
  17. Bontemps C, Cannistrà C, Michel P, Butler-Browne GS, Fonzi L, Barbet JP (2002) The persistence of ontogenic characteristics in the adult masseter muscle. Bull Group Int Rech Sci Stomatol Odontol 44:61–67
  18. Bouchard J-P, Gagné F, Tomé FMS, Brunet D (1989) Nuclear inclusions in oculopharyngeal muscular dystrophy in Quebec. Can J Neurol Sci 16:446–450. https://doi.org/10.1017/S0317167100029565 · doi:10.1017/s0317167100029565
  19. Brais B, Bouchard JP, Xie YG, Rochefort DL, Chrétien N, Tomé FM et al (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18:164–167. https://doi.org/10.1038/ng0298-164 · DOI · Paper page
  20. Calado A, Tomé FM, Brais B, Rouleau GA, Kühn U, Wahle E et al (2000) Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet 9:2321–2328 · DOI · Paper page
  21. Chartier A, Klein P, Pierson S, Barbezier N, Gidaro T, Casas F et al (2015) Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis. PLoS Genet 11:e1005092. https://doi.org/10.1371/journal.pgen.1005092 · DOI
  22. Chen Z, Sequeiros J, Tang B, Jiang H (2018) Genetic modifiers of age-at-onset in polyglutamine diseases. Ageing Res Rev 48:99–108. https://doi.org/10.1016/j.arr.2018.10.004 · DOI
  23. Cobley JN, Sakellariou GK, Murray S, Waldron S, Gregson W, Burniston JG et al (2013) Lifelong endurance training attenuates age-related genotoxic stress in human skeletal muscle. Longevity & Healthspan 2:11. https://doi.org/10.1186/2046-2395-2-11 · DOI · Paper page
  24. Coquet M, Vital C, Julien J (1990) Presence of inclusion body myositis-like filaments in oculopharyngeal muscular dystrophy. Ultrastructural study of 10 cases. Neuropathol Appl Neurobiol 16:393–400 · doi:10.1111/j.1365-2990.1990.tb01275.x
  25. Cruz-Aguilar M, Guerrero-de Ferran C, Tovilla-Canales JL, Nava-Castañeda A, Zenteno JC (2017) Characterization of PABPN1 expansion mutations in a large cohort of Mexican patients with oculopharyngeal muscular dystrophy (OPMD). J Investig Med 65:705–708. https://doi.org/10.1136/jim-2016-000184 · doi:10.1136/jim-2016-000184
  26. Davies JE, Wang L, Garcia-Oroz L, Cook LJ, Vacher C, O’Donovan DG et al (2005) Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med 11:672–677. https://doi.org/10.1038/nm1242 · DOI · Paper page
  27. De Smet F, Saiz Rubio M, Hompes D, Naus E, De Baets G, Langenberg T et al (2016) Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation. J Pathol. https://doi.org/10.1002/path.4872 · DOI · Paper page
  28. Duncan EJ, Cheetham ME, Chapple JP, van der Spuy J (2015) The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease. Subcell Biochem 78:243–273. https://doi.org/10.1007/978-3-319-11731-7_12 · DOI
  29. Fronz K, Otto S, Kölbel K, Kühn U, Friedrich H, Schierhorn A et al (2008) Promiscuous modification of the nuclear Poly(A)-binding protein by multiple protein-arginine methyltransferases does not affect the aggregation behavior. J Biol Chem 283:20408–20420. https://doi.org/10.1074/jbc.M802329200 · doi:10.1074/jbc.m802329200
  30. Gidaro T, Negroni E, Perié S, Mirabella M, Lainé J, St Guily JL et al (2013) Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients. J Neuropathol Exp Neurol 72:234–243. https://doi.org/10.1097/NEN.0b013e3182854c07 · DOI
  31. Hill ME, Creed GA, McMullan TF, Tyers AG, Hilton-Jones D, Robinson DO et al (2001) Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a UK population. Brain 124:522–526 · doi:10.1093/brain/124.3.522
  32. Jouan L, Rocheford D, Szuto A, Carney E, David K, Dion PA et al (2014) An 18 alanine repeat in a severe form of oculopharyngeal muscular dystrophy. Can J Neurol Sci 41:508–511 · DOI · Paper page
  33. Kehoe P, Krawczak M, Harper PS, Owen MJ, Jones AL (1999) Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet 36:108–111
  34. Kim E, Wu F, Lim D, Zeuthen C, Zhang Y, Allen J et al (2022) Fibroadipogenic progenitors regulate the basal proliferation of satellite cells and homeostasis of pharyngeal muscles via HGF secretion. Front Cell Dev Bio. https://doi.org/10.3389/fcell.2022.875209 · DOI · Paper page
  35. Klein P, Oloko M, Roth F, Montel V, Malerba A, Jarmin S et al (2016) Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing. Nucleic Acids Res. https://doi.org/10.1093/nar/gkw703 · DOI · Paper page
  36. de Klerk E, Venema A, Anvar SY, Goeman JJ, Hu O, Trollet C et al (2012) Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation. Nucleic Acids Res 40:9089–9101. https://doi.org/10.1093/nar/gks655 · DOI · Paper page
  37. Krisko A, Radman M (2019) Protein damage, ageing and age-related diseases. Open Biol 9:180249. https://doi.org/10.1098/rsob.180249 · DOI · Paper page
  38. de Leeuw RH, Garnier D, Kroon RMJM, Horlings CGC, de Meijer E, Buermans H et al (2018) Diagnostics of short tandem repeat expansion variants using massively parallel sequencing and componential tools. Eur J Hum Genet. https://doi.org/10.1038/s41431-018-0302-4 · DOI
  39. Malerba A, Klein P, Bachtarzi H, Jarmin SA, Cordova G, Ferry A et al (2017) PABPN1 gene therapy for oculopharyngeal muscular dystrophy. Nat Commun 8:14848. https://doi.org/10.1038/ncomms14848 · DOI · Paper page
  40. Malerba A, Roth F, Harish P, Dhiab J, Lu-Nguyen N, Cappellari O et al (2019) Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy. Hum Mol Genet 28:1694–1708. https://doi.org/10.1093/hmg/ddz007 · DOI · Paper page
  41. McLoon LK, Wirtschafter J (2002) Activated satellite cells are present in uninjured extraocular muscles of mature mice. Trans Am Ophthalmol Soc 100:119–124
  42. McLoon LK, Wirtschafter J (2003) Activated satellite cells in extraocular muscles of normal adult monkeys and humans. Invest Ophthalmol Vis Sci 44:1927–1932. https://doi.org/10.1167/iovs.02-0673 · DOI
  43. Mirabella M, Silvestri G, de Rosa G, Di Giovanni S, Di Muzio A, Uncini A et al (2000) GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. Neurology 54:608–614 · doi:10.1212/wnl.54.3.608
  44. Müller T, Schröder R, Zierz S (2001) GCG repeats and phenotype in oculopharyngeal muscular dystrophy. Muscle Nerve 24:120–122 · doi:10.1002/1097-4598(200101)24:1<120::aid-mus17>3.0.co;2-0
  45. Muraine L, Bensalah M, Dhiab J, Cordova G, Arandel L, Marhic A et al (2020) Transduction efficiency of adeno-associated virus serotypes after local injection in mouse and human skeletal muscle. Hum Gene Ther 31:233–240. https://doi.org/10.1089/hum.2019.173 · DOI
  46. Murshid A, Eguchi T, Calderwood SK (2013) Stress proteins in aging and life span. Int J Hyperthermia 29:442–447. https://doi.org/10.3109/02656736.2013.798873 · DOI
  47. Ramaswami M, Taylor JP, Parker R (2013) Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 154:727–736. https://doi.org/10.1016/j.cell.2013.07.038 · DOI · Paper page
  48. Randolph ME, Phillips BL, Choo H-J, Vest KE, Vera Y, Pavlath GK (2015) Pharyngeal satellite cells undergo myogenesis under basal conditions and are required for pharyngeal muscle maintenance. Stem Cells 33:3581–3595. https://doi.org/10.1002/stem.2098 · DOI · Paper page
  49. Riaz M, Raz Y, van Putten M, Paniagua-Soriano G, Krom YD, Florea BI et al (2016) PABPN1-dependent mRNA processing induces muscle wasting. PLoS Genet 12:e1006031. https://doi.org/10.1371/journal.pgen.1006031 · DOI
  50. Ribot C, Soler C, Chartier A, Hayek SA, Naït-SaïdiNbarbezier RN et al (2022) Activation of the ubiquitin-proteasome system contributes to oculopharyngeal muscular dystrophy through muscle atrophy. PLoS Genet 18:e1010015. https://doi.org/10.1371/journal.pgen.1010015 · DOI · Paper page
  51. Richard P, Trollet C, Gidaro T, Demay L, Brochier G, Malfatti E et al (2015) PABPN1 (GCN)11 as a dominant allele in oculopharyngeal muscular dystrophy –consequences in clinical diagnosis and genetic counselling. J Neuromuscul Dis 2:175–180. https://doi.org/10.3233/JND-140060 · DOI · Paper page
  52. Richard P, Trollet C, Stojkovic T, de Becdelievre A, Perie S, Pouget J et al (2017) Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy. Neurology 88:359–365. https://doi.org/10.1212/WNL.0000000000003554 · DOI
  53. Rutledge BS, Choy W-Y, Duennwald ML (2022) Folding or holding? – Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative disease. J Biol Chem. https://doi.org/10.1016/j.jbc.2022.101905 · DOI
  54. Sambasivan R, Kuratani S, Tajbakhsh S (2011) An eye on the head: the development and evolution of craniofacial muscles. Development 138:2401–2415. https://doi.org/10.1242/dev.040972 · DOI · Paper page
  55. Seidel K, Siswanto S, Fredrich M, Bouzrou M, Brunt ER, van Leeuwen FW et al (2016) Polyglutamine aggregation in Huntington’s disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation. Neuropathol Appl Neurobiol 42:153–166. https://doi.org/10.1111/nan.12253 · DOI
  56. Shan J, Chen B, Lin P, Li D, Luo Y et al (2014) Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a Chinese population. Neuromolecular Med 16:782–786. https://doi.org/10.1007/s12017-014-8327-5 · doi:10.1007/s12017-014-8327-5
  57. Shen NY, Ng SY, Toepp SL, Ljubicic V (2018) Protein arginine methyltransferase expression and activity during myogenesis. Biosci Rep. https://doi.org/10.1042/BSR20171533 · DOI
  58. Shi C, Huang X, Zhang B, Zhu D, Luo H, Lu Q et al (2015) The inhibition of heat shock protein 90 facilitates the degradation of poly-alanine expanded Poly (A) binding protein nuclear 1 via the carboxyl terminus of heat shock protein 70-interacting protein. PLoS ONE 10:e0138936. https://doi.org/10.1371/journal.pone.0138936 · DOI
  59. van der Sluijs BM, Raz V, Lammens M, van den Heuvel LP, Voermans NC, van Engelen BGM (2016) Intranuclear aggregates precede clinical onset in oculopharyngeal muscular dystrophy. J Neuromuscul Dis 3:101–109. https://doi.org/10.3233/JND-150118 · DOI
  60. Stål P, Eriksson PO, Schiaffino S, Butler-Browne GS, Thornell LE (1994) Differences in myosin composition between human oro-facial, masticatory and limb muscles: enzyme-, immunohisto- and biochemical studies. J Muscle Res Cell Motil 15:517–534. https://doi.org/10.1007/BF00121158 · DOI
  61. Tavanez JP, Bengoechea R, Berciano MT, Lafarga M, Carmo-Fonseca M, Enguita FJ (2009) Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1. PLoS ONE 4:e6418. https://doi.org/10.1371/journal.pone.0006418 · DOI
  62. Tomé FM, Askanas V, Engel WK, Alvarez RB, Lee CS (1989) Nuclear inclusions in innervated cultured muscle fibers from patients with oculopharyngeal muscular dystrophy. Neurology 39:926–932 · doi:10.1212/wnl.39.7.926
  63. Tomé FM, Fardeau M (1980) Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol 49:85–87 · DOI
  64. Tomé FMS, Chateau D, Helbling-Leclerc A, Fardeau M (1997) Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul Disord 7:S63–S69. https://doi.org/10.1016/S0960-8966(97)00085-0 · DOI
  65. Tomé FMS, Fardeau M (1980) Nuclear inclusion in oculopharyngeal dystrophy. Acta Neuropathol 49:85–87. https://doi.org/10.1007/BF00692226 · DOI
  66. Tondo M, Gámez J, Gutiérrez-Rivas E, Medel-Jiménez R, Martorell L (2012) Genotype and phenotype study of 34 Spanish patients diagnosed with oculopharyngeal muscular dystrophy. J Neurol 259:1546–1552. https://doi.org/10.1007/s00415-011-6374-5 · doi:10.1007/s00415-011-6374-5
  67. Van Der Sluijs BM, Hoefsloot LH, Padberg GW, Van Der Maarel SM, Van Engelen BGM (2003) Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint. J Neurol 250:1307–1312. https://doi.org/10.1007/s00415-003-0201-6 · doi:10.1007/s00415-003-0201-6
  68. Vest KE, Phillips BL, Banerjee A, Apponi LH, Dammer EB, Xu W et al (2017) Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology. Hum Mol Genet 26:3235–3252. https://doi.org/10.1093/hmg/ddx206 · DOI · Paper page
  69. Wang L, Jia Z, Xie D, Zhao T, Tan Z, Zhang S et al (2020) Methylation of HSP70 orchestrates its binding to and stabilization of BCL2 mRNA and renders pancreatic cancer cells resistant to therapeutics. Can Res 80:4500–4513. https://doi.org/10.1158/0008-5472.CAN-19-1738 · DOI
  70. Wang Q, Mosser DD, Bag J (2005) Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells. Hum Mol Genet 14:3673–3684 · DOI
  71. Zhang Y, King OD, Rahimov F, Jones TI, Ward CW, Kerr JP et al (2014) Human skeletal muscle xenograft as a new preclinical model for muscle disorders. Hum Mol Genet 23:3180–3188. https://doi.org/10.1093/hmg/ddu028 · DOI

Metadata

Authors
Roth, F., Dhiab, J., Boulinguiez, A., Mouigni, H.-R., Lassche, S., Negroni, E., Muraine, L., Marhic, A., Oliver, A., Lainé, J., Rouche, A., O’Ferrall, E. K., van Engelen, B., Ottenheijm, C., Greif, H., Blumen, S., Lacau St Guily, J., Perie, S., Butler-Browne, G., Mouly, V., & Trollet, C.
Venue
Acta Neuropathologica
Published
2022-10-05
Volume
144
Issue
6
Pages
1157-1170
ISSN
  • 0001-6322
  • 1432-0533
Cited by
18
References
1
Language
en
Licence
Funders
  • AFM-Téléthon
  • Institut national de la santé et de la recherche médicale
  • Sorbonne Université
  • Fondation pour la Recherche Médicale (EQUIPE FRM EQU201903007784, M2R201803006410)
  • Fondation Maladies Rares (AP-RM-16-035)
  • Prinses Beatrix Spierfonds (W.OR10-30)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy. https://app.cochat.ai/papers/10.1007/s00401-022-02503-7
The paper
Roth, F., Dhiab, J., Boulinguiez, A., Mouigni, H.-R., Lassche, S., Negroni, E., Muraine, L., Marhic, A., Oliver, A., Lainé, J., Rouche, A., O’Ferrall, E. K., van Engelen, B., Ottenheijm, C., Greif, H., Blumen, S., Lacau St Guily, J., Perie, S., Butler-Browne, G., . . . Trollet, C. (2022). Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy. Acta Neuropathologica. https://doi.org/10.1007/s00401-022-02503-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.